![Christopher M. Bussineau](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher M. Bussineau
Directeur des opérations chez
BioVascular, Inc.
Profil
Christopher M.
Bussineau is currently the Vice President-Pharmaceutical Operations at BioVascular, Inc. He previously worked as the Senior Director-Technical Operations at Chiron Corp.
and as the Vice President & General Manager at Cambrex Bio Science Baltimore, Inc. Bussineau holds a doctorate degree from Rice University and an undergraduate degree from the University of California San Diego.
Postes actifs de Christopher M. Bussineau
| Sociétés | Poste | Début |
|---|---|---|
BioVascular, Inc.
 BioVascular, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and devices for control of intimal hyperplasia associated with vascular procedures | Directeur des opérations | - |
Anciens postes connus de Christopher M. Bussineau
| Sociétés | Poste | Fin |
|---|---|---|
Cambrex Bio Science Baltimore, Inc. | Corporate Officer/Principal | - |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Directeur Technique/Scientifique/R&D | - |
Formation de Christopher M. Bussineau
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Rice University
 Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioVascular, Inc.
BioVascular, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and devices for control of intimal hyperplasia associated with vascular procedures | Health Technology |
Cambrex Bio Science Baltimore, Inc. |
